The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,238.00
Bid: 12,236.00
Ask: 12,240.00
Change: -8.00 (-0.07%)
Spread: 4.00 (0.033%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar holds firm in cautious trading before Fed meets

Tue, 16th Mar 2021 04:29

* Yen hovers at nine-month lows, euro flat
* Focus on Fed comments about higher bond yields
* Sterling dips ahead of BoE meeting on Thursday
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

(Adds analyst comments; updates prices)
By Kevin Buckland and Sagarika Jaisinghani
TOKYO, March 16 (Reuters) - The U.S. dollar clung to small
gains on Tuesday as caution reigned in currency markets ahead of
major central bank meetings, beginning with a two-day Federal
Reserve gathering due to start later in the global day.
The greenback hovered just off its highest since June versus
the yen and cemented a position around $1.19 per euro
in muted trading.
The firmer tone for the dollar came despite a retreat in
U.S. benchmark yields from the highest levels in more than a
year ahead of the Fed meeting.
Expectations are running low for monetary policymakers to
shift from their accommodative stance despite forecasts of rapid
economic growth in the wake of an accelerating COVID-19 vaccine
roll-out and a $1.9 trillion pandemic relief package.

Investors will pore over whatever the Fed has to say about
the run-up in yields, which have risen on bets that economic
growth and inflation could prompt a faster-than-expected
normalisation of monetary policy.
"It's a very pivotal meeting from that perspective," said
Mayank Mishra, an FX strategist at Standard Chartered Bank in
Singapore.
"The other thing that is being awaited is any decision on
the supplemental leverage ratio (SLR) exemption. We don't expect
any explicit push back on back-end yields, but an extension of
the SLR can offer some relief to the market."
The SLR exemption, a regulatory break that allows big banks
to exclude reserve deposits and Treasuries from capital ratios,
is due to expire on March 31.
The dollar was little changed at 109.170 yen after rising to
a nine-month high of 109.365 on Monday. The Bank of Japan begins
a two-day policy meeting on Thursday, along with an extensive
policy review.
The euro was largely flat at $1.19330, languishing below
$1.20 since March 5. Europe's vaccine roll-out has been hampered
by the suspension of AstraZeneca shots in Germany,
France and other nations amid concerns about possible serious
side effects.
Sterling fell about 0.2% to $1.3871 ahead of a Bank
of England meeting on Thursday, where the central bank is
expected to keep its benchmark interest rate at its historic low
of 0.1% and its bond-buying programme unchanged.
The dollar's index against six major currencies was flat at
91.798 after rising nearly 0.2% on Monday.
The Australian dollar, viewed widely as a liquid
proxy for risk appetite, and the New Zealand dollar were
little changed against the U.S. dollar. The commodity-linked
currencies are on course to post their fourth straight quarterly
gain as commodity prices rebound on bets of economic growth.
Bitcoin, meanwhile, slipped to $54,198.64 following its jump
to a record $61,781.83 on Saturday.

========================================================
Currency bid prices at 0400 GMT
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar $1.1934 $1.1929 +0.04% -2.32% +1.1937 +1.1923
Dollar/Yen 109.1550 109.1200 +0.06% +5.71% +109.2400 +109.1900
Euro/Yen 130.26 130.16 +0.08% +2.63% +130.3900 +130.1400
Dollar/Swiss 0.9266 0.9275 -0.10% +4.74% +0.9279 +0.9266
Sterling/Dollar 1.3869 1.3900 -0.21% +1.53% +1.3903 +1.3867
Dollar/Canadian 1.2478 1.2473 +0.05% -2.00% +1.2487 +1.2468
Aussie/Dollar 0.7752 0.7756 -0.05% +0.77% +0.7755 +0.7742
NZ 0.7195 0.7200 +0.00% +0.26% +0.7205 +0.7195
Dollar/Dollar


All spots
Tokyo spots
Europe spots
Volatilities
Tokyo Forex market info from BOJ



(Reporting by Kevin Buckland in Tokyo and Sagarika Jaisinghani
in Bengaluru; Editing by Christopher Cushing & Simon
Cameron-Moore)

More News
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.